Back to Dividend Stocks
Innoviva Inc. (INVA) logo

Innoviva Inc.

S&P 500

INVA/Healthcare · Biotechnology/NASDAQ

Dividend Yield

4.41%

$1.00 · Annual Dividend

Stock Price$23.35P/E3.6MCap1.7BLast update: Jun 26, 2026 at 06:56

Dividend Safety Rating

86/ 100Very Safe

INVA's dividend appears very safe. Strengths include a 0.0% earnings payout ratio & 0.0% fcf payout ratio. Areas of concern: Volatile profit margin stability & 1+ yrs dividend streak.

Based on 13 of 15 metrics

Strengths

  • Earnings Payout Ratio: 0.0%Low earnings payout ratio leaves room to grow the dividend.
  • FCF Payout Ratio: 0.0%Free cash flow comfortably covers the dividend.
  • Interest Coverage: 20.6xEarnings cover interest payments many times over.

Risks

  • Dividend Streak: 1+ yrsShort dividend history limits track-record signal.
  • Profit Margin Stability: VolatileProfit margins have been volatile.

Payout & Coverage

Very Safe

Balance Sheet

Very Safe
21.1xVery Safe
24.7Very Safe

Profitability

Safe
50.7%Very Safe
40.1%Very Safe
84.1%Very Safe

Dividend Track Record

Safe
1+ yrsDanger
NoneVery Safe
GrowingVery Safe

About Innoviva Inc.

Innoviva Inc. is an innovative pharmaceutical company, focusing primarily on managing royalty portfolios that originate from collaborations with external partners. This asset plays a significant role in the healthcare sector, specifically within the pharmaceuticals and biotechnology industries. The company is involved in the development and commercialization of products in the respiratory disease space, notably co-developing medicines that address chronic obstructive pulmonary disease (COPD) and asthma. Innoviva Inc.'s strategy revolves around optimizing the value of its intellectual property through strategic partnerships with major pharmaceutical players. By leveraging its royalty agreements, the company aims to maximize returns while minimizing direct operational risks associated with drug development. Founded in 1996 as Theravance, the firm transitioned to Innoviva Inc., illustrating a shift towards focusing on royalty management and investment in biopharmaceutical innovations. This positioning allows Innoviva to have a significant presence in the market, impacting the treatment approaches in the respiratory disease segment and contributing to the broader pharmaceutical and healthcare ecosystem."}

Dividend Overview

Dividend Yield

4.41%

Annual Dividend

$1.00

Frequency

Quarterly

Payout Ratio

0.00%

FCF Payout Ratio

0.00%

52-Week Range

$16.52 - $25.15

Dividend History (2016–2025)

INVA annual dividend per share and yield history

Earnings & Profitability

INVA earnings per share and net profit margin

Key Dates

Last Ex-Dividend Date

September 8, 2015

Last Payment Date

September 30, 2015

Dividend Growth

3-Year Dividend CAGR

N/A

5-Year Dividend CAGR

N/A

10-Year Dividend CAGR

N/A

3-Year Total Growth

N/A

5-Year Total Growth

N/A

10-Year Total Growth

N/A

Income Calculator

INVA Dividend Calculator

Total Investment

$2,335.00

Annual Income

$100.00

Quarterly Income

$25.00

Monthly Income

$8.33

Frequently Asked Questions

What is INVA's current dividend yield?
Innoviva Inc. (INVA) currently has a dividend yield of 4.41%, based on a stock price of $23.35 and an annual dividend of $1.00.
When is INVA's next dividend payment date?
INVA's next ex-dividend date is 2015-09-08 and the next payment date is 2015-09-30. You must own the stock before the ex-dividend date to receive the upcoming payment.
How much does INVA pay in dividends per year?
Innoviva Inc. paid $0.75 per share in annual dividends in 2015. The dividends are paid quarterly.
Has INVA been increasing its dividend?
Innoviva Inc. has grown its dividend at a 5-year CAGR of —.
Is INVA's dividend safe?
Innoviva Inc. has a payout ratio of 0.00%. Its free cash flow payout ratio is 0.00%. A payout ratio below 60% is generally considered sustainable.
How is INVA's Dividend Safety Rating calculated?
The Dividend Safety Rating evaluates Innoviva Inc.'s dividend sustainability across four categories: Payout & Coverage (30%), Balance Sheet (20%), Profitability (20%), and Dividend Track Record (30%). Each metric is rated from "Very Safe" to "Danger" based on industry-standard thresholds, with sector-specific adjustments for healthcare companies. The overall score ranges from 0 to 100.

Want to understand how we rate dividend safety? Read our full methodology

Track INVA Dividends with OnlyDividends

What will INVA actually pay you after taxes? Track every payout, get notified on payment dates, and stop guessing.

Download the App

This page is not investment advice. The content is for informational purposes only and should not be construed as a recommendation to buy, sell, or hold any security. Always do your own research and consult a qualified financial advisor before making investment decisions.

Financial data, including dividend history, earnings, balance sheet metrics, and the Dividend Safety Rating, is provided for informational purposes only. Data may be delayed or differ from official filings. Past performance does not guarantee future results. Always verify with official sources before making investment decisions.

Market data provided by Twelve Data.